Sinphar Pharmaceutical Co Ltd (1734) — Long-term Investment Intensity
Sinphar Pharmaceutical Co Ltd (1734) has a Long-term Investment Intensity of 0.5% as of December 2019. Long-term investments of NT$30.39 Million represent 0.5% of total assets of NT$5.92 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 1734 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sinphar Pharmaceutical Co Ltd Long-term Investment Intensity (2013–2019)
This chart shows how Sinphar Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 0.5%, reflecting long-term investments of NT$30.39 Million against total assets of NT$5.92 Billion TWD. For the complete balance sheet picture, see Sinphar Pharmaceutical Co Ltd assets under control.
Annual Long-term Investment Intensity for Sinphar Pharmaceutical Co Ltd (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Sinphar Pharmaceutical Co Ltd from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Sinphar Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.5% | NT$30.39 Million | NT$5.92 Billion | ▼ -0.5 pp |
| 2018 | 1.0% | NT$58.87 Million | NT$5.88 Billion | ▼ -0.7 pp |
| 2017 | 1.7% | NT$102.65 Million | NT$6.04 Billion | ▲ +0.2 pp |
| 2016 | 1.5% | NT$90.44 Million | NT$6.21 Billion | ▼ -2.3 pp |
| 2015 | 3.7% | NT$238.34 Million | NT$6.39 Billion | ▲ +2.0 pp |
| 2014 | 1.7% | NT$110.19 Million | NT$6.46 Billion | ▲ +0.2 pp |
| 2013 | 1.5% | NT$86.63 Million | NT$5.70 Billion | — |